Right. I think that means that they have found a couple of diagnostics companies with revenue who may want to invest in AMBS in exchange for shares of the diagnostics subsidiary as part of the spin-out.
Nice to hear that there is more than one party interested.
He also said that same party would be a commercialization partner for MSPrecise. Launching late 2016/early 2017.
(0)
(0)
Amarantus Bioscience Holdings (AMBS) Stock Research Links